Daniel Dransfield PhD

Daniel Dransfield was Experienced scientific professional with over 20 years of drug development/research experience in industry and academia. Drug discovery and development experience at multiple biotechnology and biopharmaceutical companies including Dyax (VP, Cell Biology and Translational Research), ArQule (VP, Discovery Research and Translational Medicine), Tokai (VP, Translational Medicine), Siamab (SVP, Research & Development) and currently Epizyme (VP, Biology, Interim Head of Research). A senior member of the Research & Development leadership teams. Project Leader/Program Director on multiple pre-clinical oncology and non-oncology programs which advanced into Development or were successfully partnered externally.